Prevalence of Dyslipidemia in Iranian Children and Adolescents: A Systematic Review

Overview

Journal J Res Med Sci

Specialty General Medicine

Date 2015 Oct 22

PMID 26487880

Citations 14

Authors

Silva Hovsepian

Roya Kelishadi

Shirin Djalalinia

Farshad Farzadfar

Shohreh Naderimagham

Mostafa Qorbani

Affiliations

Soon will be listed here.

Abstract

Background: Dyslipidemia is considered as an important modifiable risk factor for cardiovascular disease (CVD). The link between childhood dyslipidemia and occurrence of atherosclerosis and its sequels in adulthood are well-documented. This study aimed to systematically review the prevalence of dyslipidemia among Iranian children and adolescents.

Materials And Methods: An electronic search was conducted on studies published from January 1990 to January 2014. The main international electronic data sources were PubMed and the NLM Gateway (for MEDLINE), Institute of Scientific Information (ISI), and SCOPUS. For Persian databases, we used domestic databases with systematic search capability including IranMedex, Irandoc, and Scientific Information Database (SID). We included all available population-based studies and national surveys conducted in the pediatric age group (aged <21 years).

Results: In this review, 1772 articles were identified (PubMed: 1464; Scopus: 11; ISI: 58; SID: 90; IranMedex: 149; Irandoc: 57). During three refine steps and after removing of duplicates, 182 articles related to the study domain were selected. After quality assessment, 46 studies were selected for text appraisal, of which 26 qualified articles were evaluated at the final step. The prevalence range of hypercholesterolemia, hypertriglyceridemia, elevated low-density lipoprotein cholesterol, and low high-density lipoprotein cholesterol (HDL-C) were 3-48%, 3-50%, 5-20% and 5-88%, respectively. Low HDL-C and hypertriglyceridemia were the most prevalent lipid disorders in this group of population.

Conclusion: Dyslipidemia is a common health problem among Iranian children and adolescents. Few data were available in preschool children. This finding provides useful information for health policy makers to implement action-oriented interventions for prevention and early control of this important CVD risk factor.

Citing Articles

The Protocol for the Development of Iranian Clinical Practice Guideline on Dyslipidemia.

Ashoorion V, Sarrafzadegan N, Shahidi S, Bagherikholenjani F ARYA Atheroscler. 2024; 19(6):27-35.

PMID: 38883849 PMC: 11178993. DOI: 10.48305/arya.2023.41868.2904.

First Iranian guidelines for the diagnosis, management, and treatment of hyperlipidemia in adults.

Bagheri Kholenjani F, Shahidi S, Vaseghi G, Ashoorion V, Sarrafzadegan N, Siavash M J Res Med Sci. 2024; 29:18.

PMID: 38808220 PMC: 11132424. DOI: 10.4103/jrms.jrms_318_23.

Lipid Profile and the Frequency of Dyslipidemia in Iranian Adolescents with Severe Obesity, Who Were Candidates for Bariatric Surgery.

Soheilipour F, Geram F Obes Surg. 2024; 34(2):618-624.

PMID: 38191967 DOI: 10.1007/s11695-023-07038-8.

Dyslipidemia in youth: Epidemiology, pathophysiology, screening, management, and treatment: A review of the literature.

Esfarjani S, Zakerkish M J Family Med Prim Care. 2023; 11(12):7519-7526.

PMID: 36994010 PMC: 10041032. DOI: 10.4103/jfmpc.jfmpc_2374_21.

Hyperlipidemia and Cardiovascular Risk in Children and Adolescents.

Mainieri F, La Bella S, Chiarelli F Biomedicines. 2023; 11(3).

PMID: 36979789 PMC: 10045454. DOI: 10.3390/biomedicines11030809.

References

Kelishadi R, Hovsepian S, Qorbani M, Jamshidi F, Fallah Z, Djalalinia S . National and sub-national prevalence, trend, and burden of cardiometabolic risk factors in Iranian children and adolescents, 1990 - 2013. Arch Iran Med. 2014; 17(1):71-80. DOI: 0141701/AIM.0011. View

Rerksuppaphol S, Rerksuppaphol L . Prevalence of dyslipidemia in Thai schoolchildren. J Med Assoc Thai. 2011; 94(6):710-5. View

Tabatabaei-Malazy O, Qorbani M, Samavat T, Sharifi F, Larijani B, Fakhrzadeh H . Prevalence of dyslipidemia in iran: a systematic review and meta-analysis study. Int J Prev Med. 2014; 5(4):373-93. PMC: 4018586. View

Zachariah J, de Ferranti S . NHLBI integrated pediatric guidelines: battle for a future free of cardiovascular disease. Future Cardiol. 2012; 9(1):13-22. PMC: 3705707. DOI: 10.2217/fca.12.72. View

Kelishadi R, Ardalan G, Gheiratmand R, Ramezani A . Is family history of premature cardiovascular diseases appropriate for detection of dyslipidemic children in population-based preventive medicine programs? CASPIAN study. Pediatr Cardiol. 2006; 27(6):729-36. DOI: 10.1007/s00246-006-1391-3. View

Esmaillzadeh A, Mirmiran P, Azadbakht L, Etemadi A, Azizi F . High prevalence of the metabolic syndrome in Iranian adolescents. Obesity (Silver Spring). 2006; 14(3):377-82. DOI: 10.1038/oby.2006.50. View

Psaty B, Rivara F . Universal screening and drug treatment of dyslipidemia in children and adolescents. JAMA. 2011; 307(3):257-8. DOI: 10.1001/jama.2011.1916. View

Hatami M, Tohidi M, Mohebi R, Khalili D, Azizi F, Hadaegh F . Adolescent lipoprotein classifications according to National Health and Nutrition Examination Survey (NHANES) vs. National Cholesterol Education Program (NCEP) for predicting abnormal lipid levels in adulthood in a Middle East population. Lipids Health Dis. 2012; 11:107. PMC: 3477115. DOI: 10.1186/1476-511X-11-107. View

Finucane M, Stevens G, Cowan M, Danaei G, Lin J, Paciorek C . National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants. Lancet. 2011; 377(9765):557-67. PMC: 4472365. DOI: 10.1016/S0140-6736(10)62037-5. View

10.

Hosseini-Esfahani F, Mousavi Nasl Khameneh A, Mirmiran P, Ghanbarian A, Azizi F . Trends in risk factors for cardiovascular disease among Iranian adolescents: the Tehran Lipid and Glucose Study, 1999-2008. J Epidemiol. 2011; 21(5):319-28. PMC: 3899430. DOI: 10.2188/jea.JE20100162. View

11.

Al-Shehri S, Saleh Z, Salama M, Hassan Y . Prevalence of hyperlipidemia among Saudi school children in Riyadh. Ann Saudi Med. 2004; 24(1):6-8. PMC: 6147826. DOI: 10.5144/0256-4947.2004.6. View

12.

Azizi F, Rahmani M, Madjid M, Allahverdian S, Ghanbili J, Ghanbarian A . Serum lipid levels in an Iranian population of children and adolescents: Tehran lipid and glucose study. Eur J Epidemiol. 2001; 17(3):281-8. DOI: 10.1023/a:1017932212350. View

13.

Mirhosseini N, Shahar S, Ghayour-Mobarhan M, Parizadeh M, Mohd Yusoff N, Shakeri M . Body fat distribution and its association with cardiovascular risk factors in adolescent Iranian girls. Iran J Pediatr. 2012; 22(2):197-204. PMC: 3446063. View

14.

Naghavi M, Abolhassani F, Pourmalek F, Lakeh M, Jafari N, Vaseghi S . The burden of disease and injury in Iran 2003. Popul Health Metr. 2009; 7:9. PMC: 2711041. DOI: 10.1186/1478-7954-7-9. View

15.

Kelishadi R, Ardalan G, Gheiratmand R, Adeli K, Delavari A, Majdzadeh R . Paediatric metabolic syndrome and associated anthropometric indices: the CASPIAN Study. Acta Paediatr. 2006; 95(12):1625-34. DOI: 10.1080/08035250600750072. View

16.

Schwandt P, Kelishadi R, Ribeiro R, Haas G, Poursafa P . A three-country study on the components of the metabolic syndrome in youths: the BIG Study. Int J Pediatr Obes. 2010; 5(4):334-41. DOI: 10.3109/17477160903497043. View

17.

. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011; 128 Suppl 5:S213-56. PMC: 4536582. DOI: 10.1542/peds.2009-2107C. View

18.

Barzin M, Hosseinpanah F, Saber H, Sarbakhsh P, Nakhoda K, Azizi F . Gender Differences Time Trends for Metabolic Syndrome and Its Components among Tehranian Children and Adolescents. Cholesterol. 2012; 2012:804643. PMC: 3345209. DOI: 10.1155/2012/804643. View

19.

Mehrkash M, Kelishadi R, Mohammadian S, Mousavinasab F, Qorbani M, Hashemi M . Obesity and metabolic syndrome among a representative sample of Iranian adolescents. Southeast Asian J Trop Med Public Health. 2012; 43(3):756-63. View

20.

Mirhosseini N, Mohd Yusoff N, Shahar S, Parizadeh S, Mobarhen M, Shakery M . Prevalence of the metabolic syndrome and its influencing factors among adolescent girls in Mashhad, Iran. Asia Pac J Clin Nutr. 2009; 18(1):131-6. View